Lv2
118 积分 2024-12-23 加入
Diverse activation mechanisms of PI3Ks
15天前
已完结
The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers
25天前
已完结
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity
29天前
已完结
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
1个月前
已完结
The endosomal-lysosomal system in ADC design and cancer therapy
2个月前
已完结
INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2个月前
已完结
Discovery and Characterization of RP03707: A Highly Potent and Selective KRASG12D PROTAC
2个月前
已完结
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition
2个月前
已完结
A patent review of BRD4 inhibitors (2020–present)
3个月前
已完结
Elucidating Critical Factors of Internalization and Drug Release of Antibody-Drug Conjugates (ADCs) Using Kinetic Parameters Evaluated by a Novel Tool Named TORCH
3个月前
已完结
皖公网安备34019202002308
